Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Seth Kirschner

Gastroenterology Coral Springs, FL Doctor of Osteopathy

NPI 1548554546 CMS profile 161253

3001 Coral Hills Dr Ste 250, Coral Springs, FL 33065

Open in the dashboard

General payments

$26,450

1,229 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Seth Kirschner of Coral Springs, FL is reported in the CMS Open Payments database as having received $26,450 across 1,229 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 90th percentile of Gastroenterology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,271 176
2024 General $4,409 183
2023 General $4,092 175
2022 General $4,381 204
2021 General $3,229 190
2020 General $2,499 135
2019 General $3,569 166

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Seth Kirschner
  • Gastroenterology median
  • Middle half of Gastroenterology
  • National median

In program year 2025, general payments to Seth Kirschner were reported at $4,271. Among 13,050 Gastroenterology profiles paid that year, the median was $639 and the middle half received between $167 and $1,700.

Show as a table
Year Seth Kirschner Gastroenterology median Middle half National median
2019 $3,569 $417 $126–$1,100 $163
2020 $2,499 $224 $74–$624 $114
2021 $3,229 $352 $106–$1,054 $132
2022 $4,381 $448 $129–$1,270 $149
2023 $4,092 $533 $150–$1,390 $160
2024 $4,409 $605 $160–$1,606 $164
2025 $4,271 $639 $167–$1,700 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $5,957 287 payments
  2. Janssen Biotech, Inc. $2,938 124 payments
  3. Takeda Pharmaceuticals U.S.A., Inc. $2,650 112 payments
  4. Salix Pharmaceuticals, a division of Bausch Health US, LLC $2,508 157 payments
  5. Madrigal Pharmaceuticals $849 30 payments
  6. Ardelyx, Inc. $792 39 payments
  7. Genzyme Corporation $792 27 payments
  8. Gilead Sciences, Inc. $771 33 payments
  9. Celgene Corporation $733 60 payments
  10. RedHill Biopharma Inc. $717 25 payments
  11. Other $7,744 335 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $26,016 1,198 payments
  2. Education $434 31 payments
Products named General payments · program years 2019–2025
  1. STELARA $2,758 98 payments
  2. XIFAXAN $2,687 165 payments
  3. ENTYVIO $1,685 60 payments
  4. RINVOQ $1,653 81 payments
  5. HUMIRA $1,470 87 payments
  6. ZEPOSIA $1,409 64 payments
  7. TREMFYA $1,380 46 payments
  8. CREON $1,277 71 payments
  9. SKYRIZI $1,028 45 payments
  10. LINZESS $963 59 payments
  11. Other $13,953 672 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 15 drugs

Part D claims

957

Median for Gastroenterology: 569

Drug cost

$134,064

Median for Gastroenterology: $104,976

Branded share of claims

41.5%

Median for Gastroenterology: 31.8%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Linzess Linaclotide Brand 105 $65,498
Clenpiq Sod Picosulf/Mag Ox/Citric Ac Brand 210 $35,822
Creon Lipase/Protease/Amylase Brand 15 $23,488
Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates Brand 56 $3,549
Omeprazole Generic 206 $1,767
Colestipol Hcl Generic 15 $928
Pantoprazole Sodium Generic 137 $880
Famotidine Generic 73 $567
Dicyclomine Hcl Generic 56 $456
Esomeprazole Magnesium Generic 16 $320

The 10 drugs with the highest cost, of 15 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,294 Part D prescribers listed as Gastroenterology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 32 billing codes

Paid by Medicare

$139,800

Of which drugs: $91,427

Medicare patients

236

Average age 73

Services billed

5,878

131 women, 105 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 52%
Diabetes 37%
Ischemic heart disease 35%
Chronic kidney disease 25%
Depression 24%
Atrial fibrillation 21%
Osteoporosis 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 33 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
STELARA
$447 — —
DUPIXENT
$427 — —
TREMFYA
$367 — —
ENTYVIO
$343 — —
RINVOQ
$322 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See more in the dashboard: 25 with a free account, all 33 with Patron

Records

1,229 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Gastroenterology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record